Seasoned venture investor and operator with experience sourcing and scaling growth-stage technology and fintech companies; specializes in deal execution, portfolio company governance and go-to-market strategy. Mitchell Pletcher combines operational leadership with investment discipline, advising founders on product-market fit, commercial expansion and capital strategy. Market-oriented profile suitable for LPs and corporate partners seeking diligence support, board-level guidance and follow-on financing coordination.
Seasoned venture investor and operator with experience sourcing and scaling growth-stage technology and fintech companies; specializes in deal execution, portfolio company governance and go-to-market strategy. Mitchell Pletcher combines operational leadership with investment discipline, advising founders on product-market fit, commercial expansion and capital strategy. Market-oriented profile suitable for LPs and corporate partners seeking diligence support, board-level guidance and follow-on financing coordination.
Operator-investor lens focused on growth-stage technology and fintech companies, emphasizing repeatable go-to-market playbooks, disciplined capital allocation and board-level governance. Prefers concentrated syndicates where operational leverage accelerates product-market fit, sales scale and follow-on financing. Underwriting favors revenue momentum, unit-economics visibility and founders receptive to hands-on strategic guidance. Time horizon is multi-year growth with active portfolio support, measured downside protection, and execution-driven risk management.
Operator-investor lens focused on growth-stage technology and fintech companies, emphasizing repeatable go-to-market playbooks, disciplined capital allocation and board-level governance. Prefers concentrated syndicates where operational leverage accelerates product-market fit, sales scale and follow-on financing. Underwriting favors revenue momentum, unit-economics visibility and founders receptive to hands-on strategic guidance. Time horizon is multi-year growth with active portfolio support, measured downside protection, and execution-driven risk management.
| Trades 214 | Longs Won 152/214 71% | Profit Factor 26.28 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $2.8M |
| Average Win $1.13M | Best Trade (Oct 07) $28.59M | Sharpe Ratio -10.89 |
| Average Loss -$105,545.32 | Worst Trade (Oct 09) -$2.86M | Z-Score 3.74 (99.98%) |
| Commissions $0 | Avg. Trade Length 1y 4m 2w 4d | Expectancy $773,141.89 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | 0.03% |
| Consecutive Losing Trades | 3,731 | 3,358 | 2,985 | 2,612 | 2,239 | 1,866 | 1,493 | 1,119 | 746 | 373 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 81,038 | $14.18M | $27.04M | - | $12.86M | 90.7% | -1.996% |
AMZN Amazon.com Inc | 106,190 | $19.48M | $27.59M | - | $8.11M | 41.62% | +2.259% |
AVGO Broadcom Inc. | 13,528 | $4.19M | $4.92M | - | $724,504.85 | 17.28% | +0.912% |
BAC Bank of America Corporation | 210,638 | $8.71M | $11.33M | - | $2.63M | 30.16% | +0.354% |
CMF iShares California Muni Bond ETF | 681 | $39,253 | $36,828.48 | - | -$2,424.52 | -6.18% | +0.148% |
COST Costco Wholesale Corporation | 4,818 | $4.46M | $4.56M | - | $102,260.21 | 2.29% | -0.102% |
CVX Chevron Corporation | 2,294 | $440,199.77 | $488,564.65 | - | $48,364.88 | 10.99% | +0.674% |
DELL Dell Technologies Inc. | 45,253 | $7.52M | $25.74M | - | $18.22M | 242.18% | -0.988% |
EEM iShares MSCI Emerging Markets ETF | 59,281 | $3.38M | $3.95M | - | $567,327.66 | 16.77% | +0.832% |
ETN Eaton Corporation plc | 24,488 | $9.17M | $10.44M | - | $1.27M | 13.83% | +0.41% |
GIS General Mills, Inc. | 2,186 | $110,218.17 | $70,137.81 | - | -$40,080.36 | -36.36% | -1.55% |
GOOG Alphabet Inc | 1,909 | $467,605.91 | $663,835.66 | - | $196,229.75 | 41.96% | +0.835% |
GOOGL Alphabet Inc | 65,560 | $10.11M | $23.02M | - | $12.91M | 127.74% | +0.834% |
HYG iShares iBoxx $ High Yield Corporate Bond ETF | 15,553 | $1.21M | $1.2M | - | -$11,322.42 | -0.94% | -0.065% |
HYS PIMCO 0-5 Year High Yield Corporate Bond Index Exchange-Traded Fund | 4,770 | $446,090 | $429,967.8 | - | -$16,122.2 | -3.61% | -0.044% |
IBB iShares Biotechnology ETF | 27,445 | $3.78M | $5.59M | - | $1.81M | 47.97% | +1.571% |
IHE iShares U.S. Pharmaceuticals ETF | 49,456 | $3.37M | $4.9M | - | $1.53M | 45.58% | +0.248% |
IHI iShares U.S. Medical Devices ETF | 42,288 | $2.48M | $2.18M | - | -$293,478.82 | -11.85% | +1.076% |
IWF iShares Russell 1000 Growth ETF | 43,657 | $5.34M | $5.57M | - | $235,086.76 | 4.4% | +0.448% |
IWO iShares Russell 2000 Growth ETF | 394 | $155,220.24 | $139,942.89 | - | -$15,277.35 | -9.84% | +0.485% |